OAK BROOK, Ill.--(BUSINESS WIRE)--May 31, 2006--Bio-Bridge Science, Inc. (OTCBB: BGES - News), a developer of vaccines with broad preventative and therapeutic applications, today announced that it has completed the major construction of a new state-of-the-art GMP research and manufacturing facility located in Beijing. The facility will provide a high quality research and production environment for the Company’s vaccine products as well as pre-clinical and clinical trials.
